Airline alliances are not joint ventures, and the difference matters for travelers

The three global alliances are Star Alliance (26 members), Oneworld (16), and SkyTeam (18). But alliance membership is a marketing and loyalty layer — it does not by itself let carriers coordinate pricing. Antitrust-immunized joint ventures are separate legal agreements where specific carriers may align schedules, capacity, and fares.

Verified joint ventures include the Delta Air Lines–Air France-KLM–Virgin Atlantic transatlantic agreement (DOT immunity granted November 2019) and three transpacific families with DOT final orders. Other JV entries remain unconfirmed.

The two layers of airline cooperation

Alliance membership is a branding and loyalty construct. Carriers in the same alliance offer some reciprocal benefits — mileage earning, lounge access, schedule connectivity — but the alliance itself does not let them coordinate prices or capacity. That distinction exists in the rulebook, not just in theory.

Antitrust-immunized joint ventures work differently. Here the regulator — usually the U.S. Department of Transportation — reviews and blesses an agreement that lets a named group of carriers plan schedules and capacity as one and price accordingly. Each one covers specific corridors, not whole networks.

The two layers move independently. ITA Airways joined Star Alliance on April 1, 2026, after leaving SkyTeam and being taken over by the Lufthansa Group.

That membership change says nothing about whether ITA sits in an immunized joint venture — the two questions are answered by different documents.

The verified matrix

The table below lays out what the U.S. Department of Transportation’s active-case records actually establish — and where they don’t. Every carrier’s alliance status sits beside its verified immunized JV or ATI record. Cells marked unconfirmed are not an error; they are the honest state of the public record.

Only one transatlantic JV has a verified final order date: the Delta Air Lines–Air France-KLM–Virgin Atlantic agreement, which received antitrust immunity in November 2019, according to the CourtListener (RECAP) record. The order’s conditional six-month provision is the last dated step in the record; nothing after it is documented.

The Star Alliance A++ joint venture — the antitrust-immunized agreement between United Airlines and the Lufthansa Group — has no distinct effective date in the DOT records. The docket that carries it predates the current agreement.

Where the matrix goes dark

Three carriers sit at the boundary of the verified record. For ITA Airways, the alliance move is clear enough — but the DOT’s retrieved records do not establish whether ITA retained, entered, or exited any separate immunized JV.

The alliance change is a membership fact. The JV question is open.

SAS left Star Alliance for SkyTeam in 2024. The carrier does turn up in older United-related immunity groupings in DOT’s active-case listings, but an old listing is not evidence of a live agreement after the alliance switch. The SAS JV cell stays unconfirmed.

Asiana Airlines is the most date-specific of the three. Asiana’s own notice states it will retain Star Alliance membership through December 16, 2026, with integration into Korean Air scheduled for December 17, 2026. The retrieved material does not say what happens to Korean Air’s existing transpacific immunity grant with Delta once the two carriers combine — whether it is rewritten, widened, or dropped.

Why the dates are so hard to pin down

The Department of Transportation organizes antitrust immunity by consolidated docket, not by current operating date. The immunity proceeding for United and Lufthansa traces to a filing that opened in the 1990s, and the current A++ agreement is a renegotiated descendant of that older record — not a fresh filing with a new date stamp. That structure is why a docket number can be decades old while the agreement it covers is current.

The transatlantic JV covering Delta, Air France, KLM, and Virgin Atlantic shows the same pattern from the other direction. Its final order is dated and public, but a final order is a legal milestone, not an operating one — the two can sit months apart, and the retrieved record only documents the first.

The three transpacific immunity families follow the same pattern. None has a separately verified commercial start date. What the dockets describe is a legal relationship between carriers, not a timetable a traveler can plan around.

What this means for a traveler

Where an immunized joint venture covers a corridor, the carriers involved are legally permitted to align fares, schedules, and capacity. That does not automatically mean they charge identical prices. It does mean the old assumption — that two carriers on a route are independent competitors — does not hold by default.

The DOT records establish corridor-level scope, not route-by-route coverage. The Delta–Air France-KLM–Virgin agreement is transatlantic; American–Japan Airlines and United–ANA concern U.S.–Japan markets; Delta–Korean Air concerns U.S.–Korea markets.

Narrowing that down to a single city pair would mean reading each carrier’s current schedules against the agreement itself — work the retrieved material does not support.

For a Western traveler, the practical move is to treat JV participation as a signal, not a verdict. On a JV-covered corridor, comparison shopping across the named carriers may not surface genuinely competing fares — and the loyalty benefits of an alliance partner may be backed by a genuine joint agreement rather than a marketing arrangement. That distinction is what the matrix above is for.

Key terms

Antitrust immunity

Antitrust immunity is a regulatory grant that lets named airlines coordinate schedules, capacity, and pricing without breaking competition law. In the United States, the Department of Transportation reviews each request, assigns it a docket number, and issues a final order setting the terms. In this article’s matrix, immunity is the dividing line: a carrier can sit inside an alliance without holding any immunized agreement, which is why several cells stay unconfirmed.

A++ joint venture

The A++ joint venture is the antitrust-immunized agreement between United Airlines and the Lufthansa Group inside the Star Alliance framework. Its immunity proceeding runs under DOT docket DOT-OST-1996-1116, a record that dates to the 1990s. Because the current agreement is a renegotiated descendant of that older filing, the docket number alone cannot tell a traveler when the present arrangement began.

DOT docket

A DOT docket is the case number the U.S. Department of Transportation assigns to a regulatory proceeding, including an antitrust-immunity review. Dockets are consolidated by proceeding rather than by current operating date, so one docket can span decades of filings. In this article, docket numbers are what anchor each immunity family — the reason the matrix cites DOT-OST-2010-0059 and DOT-OST-2002-11842 alongside start dates that remain unconfirmed.

Final Order

A final order is the Department of Transportation’s formal decision closing an antitrust-immunity proceeding and setting out the terms of the grant. It carries a date and a docket reference, and it may attach conditions such as a six-month implementation window. In this article, final orders are the firmest dates on the record, which is why the matrix lists them for every immunity family while leaving the operating dates blank.

Questions? Answers.